Avraham Beigelman, Charles W Goss, Jinli Wang, Mythili Srinivasan, Jonathan Boomer, Yanjiao Zhou, Sarah Bram, Timothy J Casper, Andrea M Coverstone, Watcharoot Kanchongkittiphon, Cadence Kuklinski, Gregory A Storch, Kenneth B Schechtman, Mario Castro, Leonard B Bacharier
BACKGROUND: Early life respiratory syncytial virus (RSV) bronchiolitis is a significant risk factor for childhood asthma. In vitro and in vivo studies suggested that decreasing levels of airway matrix metalloproteinase (MMP)-9 during RSV bronchiolitis may be associated with clinical benefits. OBJECTIVE: To investigate whether azithromycin therapy during severe RSV bronchiolitis reduces upper airway MMP-9 levels, whether upper airway MMP-9 levels correlate with upper airway interleukin IL-8 levels, and whether MMP-9 level reduction is associated with reduced post-RSV recurrent wheeze (RW)...
January 17, 2024: Annals of Allergy, Asthma & Immunology